{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:26:11Z","timestamp":1749853571110,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.dld.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T11:00:38Z","timestamp":1491130838000},"page":"883-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Robyn","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Shannahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne K.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6054-4593","authenticated-orcid":false,"given":"Suneeta","family":"Krishnareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.03.018_bib0005","article-title":"Celiac disease and non-celiac gluten sensitivity","volume":"351","author":"Lebwohl","year":"2015","journal-title":"BMJ: British Medical Journal"},{"key":"10.1016\/j.dld.2017.03.018_bib0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.03.018_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jcgh.2003.50004","article-title":"Trends in the identification and clinical features of celiac disease in a North American community, 1950\u20132001","volume":"1","author":"Murray","year":"2003","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2017.03.018_bib0020","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2012.219","article-title":"The prevalence of celiac disease in the United States","volume":"107","author":"Rubio-Tapia","year":"2012","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.03.018_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.dld.2017.03.018_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1756283X12437358","article-title":"Overutilization of proton-pump inhibitors: what the clinician needs to know","volume":"5","author":"Heidelbaugh","year":"2012","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"10.1016\/j.dld.2017.03.018_bib0035","first-page":"e56060","article-title":"Proton pump inhibitor use in the U.S. ambulatory setting, 2002\u20132009","volume":"8","author":"Rotman","year":"2013","journal-title":"Public Library of Science"},{"key":"10.1016\/j.dld.2017.03.018_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dld.2013.08.128","article-title":"Use of proton pump inhibitors and subsequent risk of celiac disease","volume":"46","author":"Lebwohl","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2017.03.018_bib0045","first-page":"G302","article-title":"Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice","volume":"307","author":"Mazzarella","year":"2014","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.dld.2017.03.018_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.giec.2012.07.001","article-title":"Histopathology of celiac disease","volume":"22","author":"Bao","year":"2012","journal-title":"Gastrointestinal Endoscopy Clinics of North America"},{"key":"10.1016\/j.dld.2017.03.018_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3164\/jcbn.10-79","article-title":"The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine","volume":"48","author":"Matsui","year":"2011","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"key":"10.1016\/j.dld.2017.03.018_bib0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/gut.49.5.650","article-title":"Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs","volume":"49","author":"Smecuol","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.03.018_bib0065","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/aje\/kwt234","article-title":"Decreased risk of celiac disease in patients with Helicobacter pylori colonization","volume":"178","author":"Lebwohl","year":"2013","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.dld.2017.03.018_bib0070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ajg.2013.45","article-title":"Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma","volume":"108","author":"DeGaetani","year":"2013","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.03.018_bib0075","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.dld.2016.05.024","article-title":"Seronegative celiac disease: shedding light on an obscure clinical entity","volume":"48","author":"Volta","year":"2016","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2017.03.018_bib0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-2036.2008.03824.x","article-title":"Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase","volume":"28","author":"Mullin","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2017.03.018_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1211\/0022357021778583","article-title":"Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue","volume":"54","author":"Hopkins","year":"2002","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.dld.2017.03.018_bib0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jclinpath-2011-200372","article-title":"Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease","volume":"65","author":"Arguelles-Grande","year":"2012","journal-title":"Journal of Clinical Pathology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817307983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817307983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T21:54:57Z","timestamp":1535925297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817307983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1590865817307983"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.03.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}